Delve into key insights from ASCO 2023, which emphasized patient-centered care in genitourinary oncology, including the efficacy of virtual prostate cancer clinics and the critical need for initiating serious-illness conversations.

Explore the ethical and legal ramifications of Montana’s new law, which significantly expands the scope of conscience objection protections for healthcare providers while raising concerns about patient care and rights.

Explore the potential of OncoNPC, an AI model that leverages gene sequencing data to predict the primary source of cancer, offering a new avenue for more targeted and effective treatments.

Explore the intricacies of diagnosing and treating acral melanoma, a subtype that presents unique challenges but also offers new avenues for targeted therapies and immune modulation.

Explore the complexities and challenges that could arise for oncologists with the potential expansion of blood biopsy insurance coverage through the MCED Screening Coverage Act.

Explore the nuanced implications of the FDA’s accelerated approval of enfortumab vedotin plus pembrolizumab for cisplatin-ineligible urothelial carcinoma patients, including questions on optimal treatment duration and adverse effects.